4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-23-005045
Interim CEO & General Counsel gave up 36,441 shares (to pay taxes)
- Interim CEO & General Counsel acquired 83,325 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vogt Frederick G Interim CEO & General Counsel | 2023-01-17 | Option exercise | +83,325 | 85,325 | D: show line 1 in the form | ||
| Vogt Frederick G Interim CEO & General Counsel | 2023-01-17 | Shares withheld for taxes | −36,441 | $6.43 | $234,316 | 48,884 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vogt Frederick G Interim CEO & General Counsel | 2023-01-17 | Option exercise · Restricted Stock Units | −83,325 | 166,675 | D: show line 3 in the form |
Loading xslF345X03/tm233853d1_4seq1.xml…